Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP552299.RAF3uPIdjKPKzSZObd-Iyt_WtQsGvREl4s8crp3dfmgFk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP552299.RAF3uPIdjKPKzSZObd-Iyt_WtQsGvREl4s8crp3dfmgFk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP552299.RAF3uPIdjKPKzSZObd-Iyt_WtQsGvREl4s8crp3dfmgFk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP552299.RAF3uPIdjKPKzSZObd-Iyt_WtQsGvREl4s8crp3dfmgFk130_provenance.
- befree-20150227 importedOn "2015-02-27" NP552299.RAF3uPIdjKPKzSZObd-Iyt_WtQsGvREl4s8crp3dfmgFk130_provenance.
- NP552299.RAF3uPIdjKPKzSZObd-Iyt_WtQsGvREl4s8crp3dfmgFk130_assertion wasGeneratedBy ECO_0000203 NP552299.RAF3uPIdjKPKzSZObd-Iyt_WtQsGvREl4s8crp3dfmgFk130_provenance.
- NP552299.RAF3uPIdjKPKzSZObd-Iyt_WtQsGvREl4s8crp3dfmgFk130_assertion wasDerivedFrom befree-20150227 NP552299.RAF3uPIdjKPKzSZObd-Iyt_WtQsGvREl4s8crp3dfmgFk130_provenance.
- NP552299.RAF3uPIdjKPKzSZObd-Iyt_WtQsGvREl4s8crp3dfmgFk130_assertion SIO_000772 23595973 NP552299.RAF3uPIdjKPKzSZObd-Iyt_WtQsGvREl4s8crp3dfmgFk130_provenance.
- NP552299.RAF3uPIdjKPKzSZObd-Iyt_WtQsGvREl4s8crp3dfmgFk130_assertion evidence source_evidence_literature NP552299.RAF3uPIdjKPKzSZObd-Iyt_WtQsGvREl4s8crp3dfmgFk130_provenance.
- NP552299.RAF3uPIdjKPKzSZObd-Iyt_WtQsGvREl4s8crp3dfmgFk130_assertion description "[Does treatment with the insulin sensitizer metformin modify the levels and activation of proteins related to the expression of the insulin-dependent glucose transporter (GLUT4), such as adenosine monophosphate-activated protein kinase (AMPK) and myocyte enhancer factor 2A (MEF2A), in endometria from hyperinsulinemic hyperandrogenemic polycystic ovary syndrome (PCOS h-Ins) patients?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP552299.RAF3uPIdjKPKzSZObd-Iyt_WtQsGvREl4s8crp3dfmgFk130_provenance.